Bypass method alone does not improve insulin resistance

Oct 29, 2010
Patrick Tso, PhD

(PhysOrg.com) -- Bypass weight-loss surgeries do not improve insulin resistance independent of weight loss, say researchers from the University of Cincinnati (UC).

"These findings should raise caution regarding the clinical investigation of duodenal bypass as a surgical or interventional treatment for type 2 …,” the authors say.

Results of the study, led by senior author Patrick Tso, PhD, of UC’s pathology and laboratory medicine department, and Tammy Kindel, MD, now at Northwestern University, are reported in the Oct. 28, 2010, advanced online publication of the journal Obesity.

Surgical procedures like the Roux-en-y gastric bypass (RYGB) include bypassing the top and middle sections of the intestine (the duodenum and jejunum). These procedures have been associated with weight loss and improvement in insulin resistance, a precursor to occurring when insulin is produced but not used properly by the body.

"There are compelling data that RYGB may improve insulin resistance beyond that which can be explained by surgical weight loss,” the authors say.

For their study, Kindel and Tso performed duodenal-jejunal bypass (DJB) on animal models with diet-induced obesity, glucose intolerance and insulin sensitivity. DJB is a modification of RYGB that does not include gastric restriction. With the stomach capacity left preserved, weight loss would not be expected after surgery and changes in could be tested independent of body weight alteration.

The UC study suggests that improved insulin sensitivity, which often follows RYGB, may be linked directly to a reduction in caloric intake or to the surgery’s exclusion of the stomach with possible changes in endocrine signaling

The authors say further investigation is needed to determine the procedure’s efficacy on glucose tolerance.

Explore further: Scientists discover new clues to how weight loss is regulated

Related Stories

Why can surgical treatment improve type 2 diabetes mellitus?

May 12, 2010

Roux-en-Y gastric bypass (RYGB) is a commonly used surgical treatment for patients with morbid obesity. It significantly and persistently decreases the levels of blood glucose and glycosylated hemoglobin in 80-100 percent ...

Be Aware of Blood Sugar Post Gastric Bypass

Jan 04, 2010

(PhysOrg.com) -- People with type 2 diabetes who have gastric bypass surgery often leave the hospital without the need for previously prescribed diabetes medications.

Gastric bypass surgery increases risk of kidney stones

Mar 10, 2010

March 11, 2010 - Patients who undergo gastric bypass surgery experience changes in their urine composition that increase their risk of developing kidney stones, research from UT Southwestern Medical Center investigators suggests.

Recommended for you

Growing a blood vessel in a week

9 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

12 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 0